|
In vitro activity of a new polyene SPK-843 against Candida spp., Cryptococcus neoformans, and Aspergillus spp. clinical isolates (click for details) |
|
|
|
A proteomics approach to study virulence in the pathogenic fungus aspergillus fumigatus (click for details) |
|
|
|
Species distribution and antifungal susceptibility of yeasts and molds isolated at Cerrahpasa Medical Faculty Department of Microbiology and Clinical Microbiology Deep Mycoses Laboratory between 02 January and 27 December 2002 (click for details) |
|
|
|
Identification of new antifungal targets by comparative genomics and proteomics (click for details) |
|
|
|
Rapid detection of pathogenic fungi from clinical specimens using real time PCR (click for details) |
|
|
|
Combination posaconazole and amphotericin B therapy against pulmonary aspergillosis and systemic candidiasis in mice (click for details) |
|
|
|
Is Aspergillus precipitins testing before lung transplantation of clinical benefit? (click for details) |
|
|
|
An open phase II study of the efficacy of micafungin (FK463) alone and in combination for the treatment of invasive aspergillosis (IA) in adults and children (click for details) |
|
|
|
The incidence of opportunistic fungi in patients suspected of tuberculosis (click for details) |
|
|
|
In vitro activity of flucytosine, caspofungin, voriconazole, and amphotericin B in 2-drug combinations against Aspergillus spp. (click for details) |
|
|
